β3-adrenergic regulation of l-type Ca2+ current and force of contraction in human ventricle

Journal of Membrane Biology

Volumn 247, Issue 4, 2014, Pages 309-318

  Treinys, Rimantas ^a   Zablockaite, Danguole ^a   Gendviliene, Vida ^a   Jurevičius, Jonas ^a   Skeberdis, V Arvydas ^a  

^a LITHUANIAN UNIVERSITY OF HEALTH SCIENCES   (Lithuania)

Author keywords

Contraction force; Human ventricle

Indexed keywords

ADOLESCENT; ADRENERGIC BETA-3 RECEPTOR AGONISTS; ADRENERGIC BETA-3 RECEPTOR ANTAGONISTS; ADULT; AGED; AGED, 80 AND OVER; AMINOPHENOLS; BIOMECHANICAL PHENOMENA; CALCIUM CHANNELS, L-TYPE; CALCIUM SIGNALING; FEMALE; HEART VENTRICLES; HUMANS; ISOPROTERENOL; MALE; MEMBRANE POTENTIALS; MIDDLE AGED; MYOCARDIAL CONTRACTION; NITRIC OXIDE SYNTHASE; PATCH-CLAMP TECHNIQUES; PHOSPHORIC DIESTER HYDROLASES; PROPANOLAMINES; RECEPTORS, ADRENERGIC, BETA-3; SULFONAMIDES; YOUNG ADULT;

EID: 84898846160     PISSN: 00222631     EISSN: 14321424     Source Type: Journal    
DOI: 10.1007/s00232-014-9635-2     Document Type: Article

References (49)

1. Abi-Gerges A, Richter W, Lefebvre F, Mateo P, Varin A, Heymes C, Samuel JL, Lugnier C, Conti M, Fischmeister R, Vandecasteele G (2009) Decreased expression and activity of cAMP phosphodiesterases in cardiac hypertrophy and its impact on beta-adrenergic cAMP signals. Circ Res 105:784-792
2. Amour J, Loyer X, Le Guen M, Mabrouk N, David JS, Camors E, Carusio N, Vivien B, Andriantsitohaina R, Heymes C, Riou B (2007) Altered contractile response due to increased beta3-adrenoceptor stimulation in diabetic cardiomyopathy: the role of nitric oxide synthase 1-derived nitric oxide. Anesthesiology 107:452-460
3. Baker JG (2005) The selectivity of beta-adrenoceptor antagonists at the human beta1, beta2 and beta3 adrenoceptors. Br J Pharmacol 144:317-322
4. Bers DM (2002) Cardiac excitation-contraction coupling. Nature 415:198-205
5. Birenbaum A, Tesse A, Loyer X, Michelet P, Andriantsitohaina R, Heymes C, Riou B, Amour J (2008) Involvement of beta 3-adrenoceptor in altered beta-adrenergic response in senescent heart: role of nitric oxide synthase 1-derived nitric oxide. Anesthesiology 109:1045-1053
6. 2+ currents in cardiac myocytes: old story, new insights. Prog Biophys Mol Biol 91:1-82
7. Brodde OE, Bruck H, Leineweber K (2006) Cardiac adrenoceptors: physiological and pathophysiological relevance. J Pharmacol Sci 100:323-337
8. Chamberlain PD, Jennings KH, Paul F, Cordell J, Berry A, Holmes SD, Park J, Chambers J, Sennitt MV, Stock MJ, Cawthorne MA, Young PW, Murphy GJ (1999) The tissue distribution of the human beta3-adrenoceptor studied using a monoclonal antibody: direct evidence of the beta3-adrenoceptor in human adipose tissue, atrium and skeletal muscle. Int J Obes Relat Metab Disord 23:1057-1065
9. Chen Z, Miao G, Liu M, Hao G, Liu Y, Fang X, Zhang Z, Lu L, Zhang J, Zhang L (2010) Age-related up-regulation of beta3-adrenergic receptor in heart-failure rats. J Recept Signal Transduct Res 30:227-233
10. Cheng HJ, Zhang ZS, Onishi K, Ukai T, Sane DC, Cheng CP (2001) Upregulation of functional beta(3)-adrenergic receptor in the failing canine myocardium. Circ Res 89:599-606
11. Christ T, Molenaar P, Klenowski PM, Ravens U, Kaumann AJ (2011) Human atrial beta(1L)-adrenoceptor but not beta(3)-adrenoceptor activation increases force and Ca(2+) current at physiological temperature. Br J Pharmacol 162:823-839
12. De Matteis R, Arch JR, Petroni ML, Ferrari D, Cinti S, Stock MJ (2002) Immunohistochemical identification of the beta(3)-adrenoceptor in intact human adipocytes and ventricular myocardium: effect of obesity and treatment with ephedrine and caffeine. Int J Obes Relat Metab Disord 26:1442-1450
13. Derici K, Samsar U, Demirel-Yilmaz E (2012) Nitric oxide effects depend on different mechanisms in different regions of the rat heart. Heart Vessels 27:89-97
14. Dessy C, Balligand JL (2010) Beta3-adrenergic receptors in cardiac and vascular tissues emerging concepts and therapeutic perspectives. Adv Pharmacol 59:135-163
15. Emorine LJ, Marullo S, Briend-Sutren MM, Patey G, Tate K, Delavier-Klutchko C, Strosberg AD (1989) Molecular characterization of the human beta 3-adrenergic receptor. Science 245:1118-1121
16. Gauthier C, Tavernier G, Charpentier F, Langin D, Le Marec H (1996) Functional beta3-adrenoceptor in the human heart. J Clin Invest 98:556-562
17. Gauthier C, Leblais V, Kobzik L, Trochu JN, Khandoudi N, Bril A, Balligand JL, Le Marec H (1998) The negative inotropic effect of beta3-adrenoceptor stimulation is mediated by activation of a nitric oxide synthase pathway in human ventricle. J Clin Invest 102:1377-1384
18. Gomez-Ospina N, Tsuruta F, Barreto-Chang O, Hu L, Dolmetsch R (2006) The C terminus of the L-type voltage-gated calcium channel Ca(V)1.2 encodes a transcription factor. Cell 127:591-606
19. Gomez-Ospina N, Panagiotakos G, Portmann T, Pasca SP, Rabah D, Budzillo A, Kinet JP, Dolmetsch RE (2013) A promoter in the coding region of the calcium channel gene CACNA1C generates the transcription factor CCAT. PLoS One 8:e60526
20. Holubarsch C, Schmidt-Schweda S, Knorr A, Duis J, Pieske B, Ruf T, Fasol R, Hasenfuss G, Just H (1994) Functional significance of angiotensin receptors in human myocardium. Significant differences between atrial and ventricular myocardium. Eur Heart J 15(Suppl D):88-91
21. Jahnel U, Rupp J, Ertl R, Nawrath H (1992) Positive inotropic response to 5-HT in human atrial but not in ventricular heart muscle. Naunyn Schmiedebergs Arch Pharmacol 346:482-485
22. Joseph SS, Lynham JA, Colledge WH, Kaumann AJ (2004) Binding of (-)-[3H]-CGP12177 at two sites in recombinant human beta 1-adrenoceptors and interaction with beta-blockers. Naunyn Schmiedebergs Arch Pharmacol 369:525-532
23. Kaumann AJ, Molenaar P (1997) Modulation of human cardiac function through 4 beta-adrenoceptor populations. Naunyn Schmiedebergs Arch Pharmacol 355:667-681
24. Kirstein M, Rivet-Bastide M, Hatem S, Benardeau A, Mercadier JJ, Fischmeister R (1995) Nitric oxide regulates the calcium current in isolated human atrial myocytes. J Clin Invest 95:794-802
25. Kong YH, Zhang Y, Li N, Zhang L, Gao YH, Xue HJ, Li Y, Li WM (2010) Association between beta3-adrenergic receptor and oxidative stress in chronic heart failure rats. Zhonghua Xin Xue Guan Bing Za Zhi 38:435-439
26. Kulandavelu S, Hare JM (2012) Alterations in beta3-adrenergic cardiac innervation and nitric oxide signaling in heart failure. J Am Coll Cardiol 59:1988-1990
27. Kuznetsov V, Pak E, Robinson RB, Steinberg SF (1995) Beta 2-adrenergic receptor actions in neonatal and adult rat ventricular myocytes. Circ Res 76:40-52
28. Leblais V, Demolombe S, Vallette G, Langin D, Baro I, Escande D, Gauthier C (1999) Beta3-adrenoceptor control the cystic fibrosis transmembrane conductance regulator through a cAMP/protein kinase A-independent pathway. J Biol Chem 274:6107-6113
29. Li H, Liu Y, Huang H, Tang Y, Yang B, Huang C (2010) Activation of beta3-adrenergic receptor inhibits ventricular arrhythmia in heart failure through calcium handling. Tohoku J Exp Med 222:167-174
30. Moniotte S, Kobzik L, Feron O, Trochu JN, Gauthier C, Balligand JL (2001a) Upregulation of beta(3)-adrenoceptors and altered contractile response to inotropic amines in human failing myocardium. Circulation 103:1649-1655
31. Moniotte S, Vaerman JL, Kockx MM, Larrouy D, Langin D, Noirhomme P, Balligand JL (2001b) Real-time RT-PCR for the detection of beta-adrenoceptor messenger RNAs in small human endomyocardial biopsies. J Mol Cell Cardiol 33:2121-2133
32. Morimoto A, Hasegawa H, Cheng HJ, Little WC, Cheng CP (2004) Endogenous beta3-adrenoreceptor activation contributes to left ventricular and cardiomyocyte dysfunction in heart failure. Am J Physiol Heart Circ Physiol 286:H2425-H2433
33. Napp A, Brixius K, Pott C, Ziskoven C, Boelck B, Mehlhorn U, Schwinger RH, Bloch W (2009) Effects of the beta3-adrenergic agonist BRL 37344 on endothelial nitric oxide synthase phosphorylation and force of contraction in human failing myocardium. J Card Fail 15:57-67
34. Niu X, Watts VL, Cingolani OH, Sivakumaran V, Leyton-Mange JS, Ellis CL, Miller KL, Vandegaer K, Bedja D, Gabrielson KL, Paolocci N, Kass DA, Barouch LA (2012) Cardioprotective effect of beta-3 adrenergic receptor agonism: role of neuronal nitric oxide synthase. J Am Coll Cardiol 59:1979-1987
35. Perera RK, Nikolaev VO (2013) Compartmentation of cAMP signalling in cardiomyocytes in health and disease. Acta Physiol (Oxf) 207:650-662
36. Puceat M, Clement O, Lechene P, Pelosin JM, Ventura-Clapier R, Vassort G (1990) Neurohormonal control of calcium sensitivity of myofilaments in rat single heart cells. Circ Res 67:517-524
37. Rasmussen HH, Figtree GA, Krum H, Bundgaard H (2009) The use of beta3-adrenergic receptor agonists in the treatment of heart failure. Curr Opin Investig Drugs 10:955-962
38. Rozec B, Gauthier C (2006) beta3-adrenoceptors in the cardiovascular system: putative roles in human pathologies. Pharmacol Ther 111:652-673
39. Rucker-Martin C, Hatem S, Dubus I, Mace L, Samuel JL, Mercadier JJ (1993) Behaviour of human atrial myocytes in culture is donor age dependent. Neuromuscul Disord 3:385-390
40. 2+: comparison with atrial receptors and relationship to (-)-[3H]-CGP 12177 binding. Br J Pharmacol 128:1445-1460
41. Sarsero D, Russell FD, Lynham JA, Rabnott G, Yang I, Fong KM, Li L, Kaumann AJ, Molenaar P (2003) (-)-CGP 12177 increases contractile force and hastens relaxation of human myocardial preparations through a propranolol-resistant state of the beta 1-adrenoceptor. Naunyn Schmiedebergs Arch Pharmacol 367:10-21
42. Schoemaker RG, Du XY, Bax WA, Bos E, Saxena PR (1993) 5-Hydroxytryptamine stimulates human isolated atrium but not ventricle. Eur J Pharmacol 230:103-105
43. Schroder E, Byse M, Satin J (2009) L-type calcium channel C terminus autoregulates transcription. Circ Res 104:1373-1381
44. Sheng L, Shen Q, Huang K, Liu G, Zhao J, Xu W, Liu Y, Li W, Li Y (2012) Upregulation of beta3-adrenergic receptors contributes to atrial structural remodeling in rapid pacing induced atrial fibrillation canines. Cell Physiol Biochem 30:372-381
45. 2+ current. J Clin Invest 118:3219-3227
46. 2+ current in human atrial myocytes. J Physiol 506(Pt 3):653-663
47. Vandecasteele G, Verde I, Rucker-Martin C, Donzeau-Gouge P, Fischmeister R (2001) Cyclic GMP regulation of the L-type Ca(2+) channel current in human atrial myocytes. J Physiol 533:329-340
48. Zhao Q, Zeng F, Liu JB, He Y, Li B, Jiang ZF, Wu TG, Wang LX (2012) Upregulation of beta3-adrenergic receptor expression in the atrium of rats with chronic heart failure. J Cardiovasc Pharmacol Ther 18:133-137
49. Zima A, Martynyuk AE, Seubert CN, Morey TE, Sumners C, Cucchiara RF, Dennis DM (2000) Antagonism of the positive dromotropic effect of isoproterenol by adenosine: role of nitric oxide, cGMP-dependent cAMP-phosphodiesterase and protein kinase G. J Mol Cell Cardiol 32:1609-1619